Stempoint Capital »

Atai Life Sciences Nv shares owned by Stempoint Capital

Quarter-by-quarter ownership of Atai Life Sciences Nv (ATAI) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Atai Life Sciences Nv

Tip: Access up to 7 years of quarterly data

All positions including Atai Life Sciences Nv held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atai Life Sciences Nv by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $402k 76k 5.29

More positions owned by Stempoint Capital

Roivant Sciences SHS (ROIV)
Uniqure Nv SHS (QURE)
Immunovant (IMVT)
Scholar Rock Hldg Corp (SRRK)
Denali Therapeutics (DNLI)
Syndax Pharmaceuticals (SNDX)
Biohaven (BHVN)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Wave Life Sciences SHS (WVE)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Ideaya Biosciences (IDYA)
Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Surrozen Com New (SRZN)

View all positions for Stempoint Capital

Top funds holding Atai Life Sciences Nv

UBS Group
Adage Capital Partners GP
Morgan Stanley
Citadel Advisors
Ally Bridge Group
ARK Investment Management
T. Rowe Price Investment Management
Susquehanna International
Millennium Management
Pale Fire Capital SE
Marshall Wace
Moore Capital Management
ADAR1 Capital Management
Jpmorgan Chase & Co
Jane Street

View all funds holding Atai Life Sciences Nv